Lorenzo Pellegrini
Fondateur chez Sentinella Pharmaceuticals, Inc.
Profil
Lorenzo Pellegrini was the founder of Palladio Biosciences, Inc. (founded in 2015) where he held the position of Chief Operating Officer.
He is also the founder of Sentinella Pharmaceuticals, Inc. Dr. Pellegrini's current job is as Managing Partner at Hatch Biofund Management LLC since 2022.
Dr. Pellegrini's former jobs include Director positions at Agile Therapeutics, Inc., Somnus Therapeutics, Inc., Cyrenaic Pharmaceuticals, Inc., and BioCritica, Inc. He was also an Independent Director at Minerva Neurosciences, Inc. from 2007 to 2014.
Dr. Pellegrini's education includes an undergraduate degree from the University of Padua, an MBA from The Wharton School of the University of Pennsylvania (conferred in 2003), and a doctorate from the Max Planck Institute For Brain Research.
Postes actifs de Lorenzo Pellegrini
| Sociétés | Poste | Début |
|---|---|---|
Sentinella Pharmaceuticals, Inc.
 Sentinella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sentinella Pharmaceuticals, Inc. manufactures pharmaceutical products. The company was Founded by Lorenzo Pellegriniis and is headquartered in Princeton, NJ. | Fondateur | - |
Hatch Biofund Management LLC
 Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Private Equity Investor | 01/10/2022 |
Anciens postes connus de Lorenzo Pellegrini
| Sociétés | Poste | Fin |
|---|---|---|
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Directeur Général | 08/08/2019 |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey. | Corporate Officer/Principal | 31/12/2015 |
| MINERVA NEUROSCIENCES, INC. | Directeur/Membre du Conseil | 29/08/2014 |
Cyrenaic Pharmaceuticals, Inc.
 Cyrenaic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyrenaic Pharmaceuticals, Inc. a private drug development company focused on the treatment of central nervous system (CNS) disorders. It specializes on the development of CYR-101, an antipsychotic in development for the treatment of schizophrenia. The company was founded in 2007 and is headquartered in Princeton, NJ. | Directeur/Membre du Conseil | 10/04/2014 |
BioCritica, Inc.
 BioCritica, Inc. Pharmaceuticals: MajorHealth Technology BioCritica is a biotechnology company focused on meeting the critical care needs of patients and clinicians in the hospital market. Simply stated, their mission is to develop and commercialize products that make a dramatic improvement in people's lives. In addition to Xigris for the treatment of severe sepsis, BioCritica is developing a pipeline of other products. The company is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | 05/07/2013 |
Formation de Lorenzo Pellegrini
| University of Padua | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Max Planck Institute For Brain Research | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| MINERVA NEUROSCIENCES, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Yale University Endowment
 Yale University Endowment Investment Trusts/Mutual FundsMiscellaneous Since 1975, the Yale Corporation Investment Committee has been responsible for oversight of the Yale University Endowment. They are located in New Haven, Connecticut | Miscellaneous |
Care Capital LLC
Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey. | Finance |
Clinical Development Capital LLC
 Clinical Development Capital LLC Finance/Rental/LeasingFinance Clinical Development Capital LLC (CDC) provides funding for ethical drug clinical trials in return for contingent milestone payments and drug royalties. The company is headquartered in Princeton, NJ | Finance |
Cyrenaic Pharmaceuticals, Inc.
Cyrenaic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyrenaic Pharmaceuticals, Inc. a private drug development company focused on the treatment of central nervous system (CNS) disorders. It specializes on the development of CYR-101, an antipsychotic in development for the treatment of schizophrenia. The company was founded in 2007 and is headquartered in Princeton, NJ. | Health Technology |
Sentinella Pharmaceuticals, Inc.
Sentinella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sentinella Pharmaceuticals, Inc. manufactures pharmaceutical products. The company was Founded by Lorenzo Pellegriniis and is headquartered in Princeton, NJ. | Health Technology |
BioCritica, Inc.
BioCritica, Inc. Pharmaceuticals: MajorHealth Technology BioCritica is a biotechnology company focused on meeting the critical care needs of patients and clinicians in the hospital market. Simply stated, their mission is to develop and commercialize products that make a dramatic improvement in people's lives. In addition to Xigris for the treatment of severe sepsis, BioCritica is developing a pipeline of other products. The company is headquartered in Indianapolis, IN. | Health Technology |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Health Technology |
Hatch Biofund Management LLC
Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Somnus Therapeutics, Inc.
 Somnus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Somnus Therapeutics, Inc. operates as a pharmaceutical company. It develops therapeutics to address the need of insomnia patients. The company was founded by Gary C. Cupit in June 2007 is headquartered in Branchburg, NJ. | Health Technology |
